Tokyo, Japan

Rikio Yabe

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Tokyo University of Science Foundation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rikio Yabe. Retrieved from https://idiyas.com/inventor/rikio-yabe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rikio Yabe: Innovator in Dendritic Cell Research

Introduction

Rikio Yabe is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunology, particularly in the activation and inhibition of dendritic cells. His innovative work has led to the development of a patent that addresses critical aspects of immune response.

Latest Patents

Rikio Yabe holds a patent for a dendritic cell immune receptor activator. This patent includes methods for activating dendritic cell immune receptors, inhibiting osteoclast formation, and preventing dendritic cell differentiation and proliferation. The patent also covers methods for inhibiting cytokine production. The active ingredient in this therapeutic method is a compound with a sugar chain, which has a basic structure represented by a specific formula.

Career Highlights

Yabe is associated with the Tokyo University of Science Foundation, where he has been able to conduct his research and develop his innovative ideas. His work has been instrumental in advancing the understanding of immune responses and potential therapeutic applications.

Collaborations

Rikio Yabe has collaborated with notable colleagues, including Yoichiro Iwakura and Tomonori Kaifu. These collaborations have further enriched his research and contributed to the development of his patented technologies.

Conclusion

Rikio Yabe's contributions to dendritic cell research exemplify the impact of innovative thinking in the field of immunology. His patent reflects a significant advancement in therapeutic methods, showcasing the potential for future developments in immune response treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…